Clinical trial
A Study of Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
NCT01215500 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
- Lead sponsor
- University of Chicago
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- March 31, 2018
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.